BORA PHARMACEUTICALS LTD Cash Flow Reinvestment Rate
BORA PHARMACEUTICALS LTD cash flow reinvestment rate. BORA PHARMACEUTICALS LTD (6472) has a Cash Flow Reinvestment Rate of 0.45x as of March 2026, reinvesting NT$258.50 Million (capex NT$211.08 Million plus investments NT$-47.42 Million) from operating cash flow of NT$568.46 Million. Explore 6472 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of BORA PHARMACEUTICALS LTD (2019–2025)
Cash flow reinvestment rate of BORA PHARMACEUTICALS LTD from 2019 to 2025. Historical reinvestment intensity for BORA PHARMACEUTICALS LTD across 7 annual periods. Explore reinvestment intensity of BORA PHARMACEUTICALS LTD to see what proportion of operating cash flow is directed to capital expenditures.
BORA PHARMACEUTICALS LTD Cash Flow Reinvestment Rate by Year (2019–2025)
BORA PHARMACEUTICALS LTD cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for BORA PHARMACEUTICALS LTD. For the full cash flow conversion analysis, see BORA PHARMACEUTICALS LTD cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | NT$953.00 Million | NT$4.24 Billion | NT$928.67 Million | ▼ -80.2% |
| 2024 | 1.13x | NT$1.11 Billion | NT$980.81 Million | NT$687.05 Million | ▲ +254.9% |
| 2023 | 0.32x | NT$1.47 Billion | NT$4.61 Billion | NT$1.43 Billion | ▲ +22.3% |
| 2022 | 0.26x | NT$524.20 Million | NT$2.01 Billion | NT$200.22 Million | ▼ -11.3% |
| 2021 | 0.29x | NT$363.58 Million | NT$1.24 Billion | NT$363.58 Million | ▼ -65.6% |
| 2020 | 0.86x | NT$152.09 Million | NT$177.79 Million | NT$152.09 Million | ▼ -71.6% |
| 2019 | 3.01x | NT$697.33 Million | NT$231.77 Million | NT$697.33 Million | — |